Company Creation
There are opportunities for investment, partnership and leadership roles with the new companies we create each year.
Our Company Creation
We support and facilitate the creation of high-tech, innovative companies. We identify and "spin out" commercial and not-for-profit activities from our world class research.
You might be interested in investing or partnering with one of our companies. Or you might want to join as an experienced executive who can support a company's growth. If you're an investor, an adviser or an academic and interested in working with us and our portfolio of companies, please get in touch.
Spin out companies
We have an excellent track record for producing spin-out companies from applied research. We also play a significant role in the development of new products and services.
Our spin out companies contribute to the development and vitality of the region through new jobs and revenue creation.
.png)
Executives into business
We support our deep tech and innovative spin-out companies to maximize their growth and success. This may involve recruiting executives with a high level of business acumen and experience in scaling up businesses.
We want to attract ambitious, experienced, and well-networked business executives to early-stage ventures. We offer remuneration and equity. We are particularly looking for executives with experience in deep tech life sciences and engineering. If you believe you have the skills and experience to lead a spin-out business, or want to find out more, get in touch.
Northern Accelerator
We are founding members of the Northern Accelerator programme. This is a collaboration between the universities in the north east of England. The programme has accelerated the commercialisation of innovation. It boosts our region’s economy, making a real-world impact from world-leading research.
Aelius Biotech
Aelius Biotech is a contract research company specialising in modelling the mucosal surfaces of the aerodigestive tract. Aelius' Integrated Model Gut System is a lab model. It stretches from the mouth to the large intestine. It can be used to test drug delivery and absorption, screen formulations, develop and test functional foods and study pre- and pro- biotics.
Alcyomics
Alcyomics is a UK based unique pre-clinical service provider using Skimune®. This is a non-artificial human skin explant for safety and efficacy assessment of novel compounds and drugs. Their aim is to provide novel solutions for pre-clinical drug safety and efficacy testing for therapeutics. This includes cellular therapies and to extend its technologies for use in the chemical and cosmetic industries.
AMLo Biosciences
AMLo Biosciences provides a prognostic test for early AJCC Stage I and Stage II melanoma. This will better identify a patient’s true risk of disease progression. They have identified two proteins (AMBLor®) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Atelerix
Atelerix offers a transformative hydrogel technology for the storage and transport of viable cells. This includes stem cells and cell-based assays at ambient temperatures. It overcomes the barriers presented by the current need for cryo-shipping. It's simple, cell-friendly and offers immediate access to stem cell therapies.
CellRev
CellRev’s mission is to be the leader in continuous cell culturing technologies. It provides clients with highly sophisticated and innovative products. They have expertise in the design and bioactivity testing of peptide-based molecules for biotechnological applications. CellRev has also developed a smart coating. This demonstrates the concept of continuous cell manufacture.
Demuris (Odyssey)
Demuris is a drug discovery and development company. It employs state-of-the-art platform technologies in natural product discovery, design and production. Demuris’ portfolio of new drug development often lies in a unique collection of Actinomycete bacteria. They can manipulate the behaviour of surrounding organisms, including bacteria, fungi, plants and animals.
ESP Diagnostics Ltd (ESPDx)
ESPDx developed a simple and accurate test for early-stage diagnosis and early pre-symptomatic detection of both dementia with Lewy Bodies and Parkinson's disease. The test measures biomarkers in extracellular vesicles. It enables early and accurate diagnosis of neurodegenerative disorders for:
- patients
- clinicians
- healthcare providers
- drug developers
GlycoScore
GlycoScore is a patented blood test that detects a panel of novel biomarkers and can accurately diagnose prostate cancer. The GlycoScore analytes are detected using a simple method called ELISA. This makes the test easily adoptable by pathology labs worldwide with no additional capital investment needed.
Indicatrix Crystallography
Indicatrix offers a unique under oil micro crystallisation technique for the crystallisation of organic soluble small molecules. This enables solid state molecular structural analysis in the pharmaceutical and chemical industries. Indicatrix performs thousands of individual experiments with only a few milligrams of analyte. It enables them to solve the most challenging industrial small molecule crystallisation problems.
JetBio
Jetbio has been established to commercialise Newcastle University's patented bioprinting technology. Their reactive jet impingement (ReJI) bioprinting technology is a fast, flexible system for printing biomimetic cell filled gels for use in developing in vitro disease models for drug testing, or to support regenerative medicine.
Marrabio
MarraBio design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide, and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. MarraBio provide a multi-functional, cost-effective solution in a single, easy to use material.
Microbritt
Microbritt is a rapid micro-manufacturing company. It's similar to 3D printing services for the manufacturing of novel complex microscale products from brittle materials, like silicon. Customers are able to make products which can't be manufactured using conventional technology. They also make them faster.
Skin Life Analytics
Skin Life Analytics developed a non-invasive test that can reveal if a person's skin is at risk of ageing prematurely. This could be from lifestyle risks such as exposure to sunlight and poor sleep, which can damage skin cells. In addition to a skin swab, the test includes a lifestyle assessment that can suggest changes to improve skin condition. They also utilise face scan technology to pinpoint areas that would benefit from a targeted care regime.
TREAT-NMD
TREAT-NMD is a network for the neuromuscular field. It provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Their focus is to develop tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development and into the clinic.
XR Therapeutics
XR Therapeutics (XRT) provides a step-change in the way therapeutic interventions for anxiety are delivered. This is for people with autism, phobias and situation-specific anxieties. XRT's product integrates traditional CBT and exposure therapies using various virtual reality environments.
Our Team
We have extensive, hands on experience of creating and successfully managing new businesses. Our team includes:
- Rick McCordall, Head of Company Creation
- Lizzie Withington, Company Creation Manager
- David Huntley, Company Creation Commercial Advisor
- James Tetley, Company Creation Commercial Advisor
- Caitlin Jardine, Company Creation Administrator
If you would like to discuss any business opportunities with the team please contact Caitlin Jardine, our Company Creation Administrator.
